Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, Tomohito Okano, Taro Yasuma, Esteban C. Gabazza, Hidenori Ibata, Tetsu Kobayashi. Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach. Diagnostics. 2024. 14. 19. 2159-2159
Suphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Atsushi Tomaru, Haruko Saiki, Mei Uemura, Yurie Kogue, Toshiyuki Ito, et al. Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human MUC5B rs35705950 Variant. Cells. 2024. 13. 18. 1523-1523
Takuya Iwamoto, Hajime Fujimoto, Tetsu Kobayashi, Esteban C. Gabazza. Lymphocyte activation markers predict the therapeutic response to immune checkpoint inhibitors: A case-control study. Cancer Medicine. 2024. 13. 12
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, Kentaro Ito, Atsushi Fujiwara, Hisamichi Yuda, Hidetoshi Itani, Masahiro Naito, Shuji Kodama, Kazuki Furuhashi, et al. Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 2024. 13. 8
Tatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, Corina N D'Alessandro-Gabazza, Masaaki Toda, Toshiyuki Ito, Atsushi Tomaru, Haruko Saiki, Tomohito Okano, Manal A B Alhawsawi, et al. Role of Microbiota-Derived Corisin in Coagulation Activation during SARS-CoV-2 Infection. Journal of thrombosis and haemostasis : JTH. 2024
Kentaro Ito, Osamu Hataji, Yuta Suzuki, Haruko Saiki, Tadashi Sakaguchi, Kosuke Hayashi, Yoichi Nishii, Fumiaki Watanabe, Tetsu Kobayashi, Esteban Gabazza, et al. The Utility of Liquid-Biopsy for Detecting EGFR Mutation in Clinical Practice: 169 Cases in a Single Institution Research Study. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S542-S542
Tadashi Sakaguchi, Osamu Hataji, Yuta Suzuki, Haruko Saiki, Kentaro Ito, Yoichi Nishii, Kosuke Hayashi, Fumiaki Watanabe, Tetsu Kobayashi, Esteban Gabazza, et al. A Retrospective Study of the Efficacy and Safety of Nivolumab in Our Clinical Practice: A Single Institutional Experience. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S1340-S1340
Kentaro Ito, Hataji Osamu, Yuta Suzuki, Saiki Haruko, Tadashi Sakaguchi, Kosuke Hayashi, Yoichi Nishii, Fumiaki Watanabe, Atsushi Fijiwara, Masamichi Yoshida, et al. Comparative Analysis of the Efficacy of Three 1st/2nd Generation EGFR-TKIs for EGFR Mutated NSCLC in Clinical Practice. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S1226-S1226
J. Hinneh, C. N. D'Alessandro-Gabazza, M. Toda, T. Yasuma, F. Kentaro, K. Nishihama, T. Kobayashi, H. Etsuko, E. Gabazza, Y. Yazunori. Preclinical efficacy of Periostin short interfering RNA in pulmonary fibrosis. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 582-582
J. Hinneh, C. N. D'Alessandro-Gabazza, M. Toda, T. Yasuma, F. Kentaro, K. Nishihama, T. Kobayashi, H. Etsuko, E. Gabazza, Y. Yazunori. Preclinical efficacy of Periostin short interfering RNA in pulmonary fibrosis. EUROPEAN JOURNAL OF IMMUNOLOGY. 2016. 46. 1250-1250